Last $14.32 USD
Change Today +0.53 / 3.84%
Volume 137.9K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher G. Chavez

Chairman, Chief Executive Officer and President, TriVascular Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 36 board members in 4 different organizations across 5 different industries.

See Board Relationships
57$1,305,771
As of Fiscal Year 2013

Background*

Mr. Christopher G. Chavez, also known as Chris is a Co-Founder of TriVascular Technologies, Inc. and has been its Chairman of the Board, Chief Executive Officer and President since April 2012. Mr. Chavez has been Chairman of the Board, Chief Executive Officer and President of TV2 Holding Company since April 2012. Mr. Chavez joined St. Jude in 2005 when it acquired Advance Neuromodulation Systems. Mr. Chavez served as Chief Executive Officer and the President of Advanced ...

Read Full Background

Corporate Headquarters*

3910 Brickway Boulevard
Santa Rosa, California 95403

United States

Phone: 707-543-8800
Fax: --

Board Members Memberships*

Co-Founder, Chairman, Chief Executive Officer and President
Director
1998-Present
Chief Executive Officer, President and Director
2002-2009
Former Director, Member of Organization, Compensation & Corporate Governance Committee, Member of Science & Technology Committee, Chief Executive Officer of Advanced Neuromodulation Systems, President of Advanced Neuromodulation Systems and Director of Advanced Neuromodulation Systems
2012-Present
Chairman, Chief Executive Officer and President

Education*

MBA 1979
Harvard Business School
Bachelor's Degree
New Mexico State University

Other Affiliations*

Annual Compensation*

Salary$450,000
Total Annual Compensation$450,000

Stock Options*

All Other Compensation$2,974
Exercisable Options Value$228,844
Unexercisable Options Value$341,107
Total Value of Options$569,951

Total Compensation*

Total Annual Cash Compensation$452,974
Total Short Term Compensation$450,000
Other Long Term Compensation$2,974
Total Calculated Compensation$1,305,771
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRIV:US $14.32 USD +0.53

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John McDermott MBAChairman of the Board and Chief Executive Officer
Endologix Inc.
$897.5K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRIVASCULAR TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.